Paul R Knight Selected Research

Anesthesia

9/2015

Halothane modulates the type i interferon response to influenza and minimizes the risk of secondary bacterial pneumonia through maintenance of neutrophil recruitment in an animal model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul R Knight Research Topics

Disease

21	Lung Injury 01/2017 - 04/2002
15	Pneumonia (Pneumonitis) 01/2017 - 09/2002
11	Inflammation (Inflammations) 04/2013 - 04/2002
10	Acute Lung Injury 01/2017 - 07/2005
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2017 - 01/2006
6	Infections 01/2016 - 11/2003
6	Wounds and Injuries (Trauma) 12/2009 - 01/2004
5	Human Influenza (Influenza) 01/2023 - 06/2010
5	Neuralgia (Stump Neuralgia) 07/2015 - 07/2002
5	Hyperalgesia 07/2015 - 07/2002
5	Surfactant Dysfunction 11/2008 - 09/2002
4	Pain (Aches) 07/2015 - 07/2002
4	Contusions 03/2013 - 08/2005
3	Necrosis 01/2023 - 08/2005
2	Bacterial Pneumonia 09/2015 - 09/2002
2	Chronic Granulomatous Disease 04/2013 - 03/2007
1	Virus Diseases (Viral Diseases) 03/2020
1	Communicable Diseases (Infectious Diseases) 11/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2015
1	Endotoxemia 01/2015
1	Ischemia 01/2015
1	Reperfusion Injury 01/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015
1	Pulmonary Aspergillosis 04/2013
1	Mycoses (Diseases, Fungus) 04/2013
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2013
1	Aspiration Pneumonia 06/2011
1	Lung Diseases (Lung Disease) 02/2011
1	Asthma (Bronchial Asthma) 02/2009

Drug/Important Bio-Agent (IBA)

12	AcidsIBA 01/2017 - 10/2004
12	CytokinesIBA 04/2013 - 07/2002
11	AlbuminsIBA 09/2015 - 04/2005
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015 - 07/2002
7	Proteins (Proteins, Gene)FDA Link 03/2020 - 09/2002
5	Surface-Active Agents (Surfactants)IBA 11/2008 - 04/2002
4	Oxidants (Oxidizing Agents)IBA 04/2013 - 04/2002
4	Virulence Factors (Pathogenicity Factors)IBA 09/2007 - 09/2003
3	Antiviral Agents (Antivirals)IBA 01/2023 - 03/2020
3	VaccinesIBA 01/2023 - 01/2016
3	Anesthetics (Anesthetic Agents)IBA 11/2017 - 04/2002
3	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2017 - 10/2004
3	LipopolysaccharidesIBA 01/2015 - 09/2003
3	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2013 - 03/2007
3	Peroxidase (Myeloperoxidase)IBA 08/2009 - 07/2005
3	Messenger RNA (mRNA)IBA 02/2009 - 07/2002
3	O Antigens (O Antigen)IBA 09/2007 - 09/2003
3	Capsules (Microcapsules)IBA 09/2007 - 09/2003
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2023 - 04/2002
2	Caspase 3 (Caspase-3)IBA 01/2023 - 08/2005
2	Halothane (Fluothane)FDA Link 09/2015 - 04/2002
2	Dietary Advanced Glycation End ProductsIBA 09/2014 - 12/2012
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2013 - 03/2005
2	GoldIBA 09/2012 - 06/2010
2	ChemokinesIBA 08/2009 - 01/2006
2	GasesIBA 08/2009 - 07/2005
2	Hemolysin Proteins (Hemolysins)IBA 03/2007 - 08/2005
2	Interleukin-6 (Interleukin 6)IBA 07/2005 - 07/2004
2	Oxygen (Dioxygen)IBA 07/2005 - 09/2002
1	Propidium (Propidium Iodide)IBA 01/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2023
1	Annexin A5IBA 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2020
1	Ketamine FDA LinkGeneric 09/2015
1	Interferon Type IIBA 09/2015
1	salicylhydroxamic acid (SHAM)IBA 07/2015
1	Small Interfering RNA (siRNA)IBA 07/2015
1	Troponin IIBA 01/2015
1	EndotoxinsIBA 01/2015
1	Advanced Glycation End ProductsIBA 09/2014
1	Adenosine Triphosphate (ATP)IBA 07/2013
1	Superoxides (Superoxide)IBA 04/2013
1	ZymosanIBA 04/2013
1	GlucansIBA 04/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2013
1	Mitochondrial DNA (mtDNA)IBA 02/2013
1	imidazoleIBA 02/2013
1	TriterpenesIBA 02/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2013
1	Pattern Recognition ReceptorsIBA 10/2012
1	Immunoglobulins (Immunoglobulin)IBA 10/2012
1	Receptor for Advanced Glycation End ProductsIBA 10/2012
1	Complementary DNA (cDNA)IBA 09/2012
1	Chemotactic FactorsIBA 06/2012
1	CCR ReceptorsIBA 06/2012
1	ProcalcitoninIBA 06/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2011
1	NanoconjugatesIBA 02/2011
1	Biomarkers (Surrogate Marker)IBA 12/2009
1	Interleukin-10 (Interleukin 10)IBA 08/2009
1	CollagenIBA 02/2009
1	Matrix Metalloproteinases (MMPs)IBA 02/2009
1	Tissue Inhibitor of Metalloproteinase-1IBA 02/2009
1	OvalbuminIBA 02/2009

Therapy/Procedure

4	Therapeutics 02/2011 - 02/2007
1	Tracheostomy 01/2017
1	Anesthesia 09/2015
1	Intraventricular Infusions 09/2012
1	Artificial Respiration (Mechanical Ventilation) 04/2011
1	Quantum Dots (Quantum Dot) 02/2011